Assignee profile:

ONO PHARMACEUTICALS CO., LTD.

City:

Osaka

Country:

Japan

Published Applications:

18

Last publication date:

2019-10-17

Patent Grants:

17

Last grant date:

2021-01-26

Top Inventors for applications by ONO PHARMACEUTICALS CO., LTD.

These are the the leading inventors for applications assigned to ONO PHARMACEUTICALS CO., LTD.:

Recent patent applications by ONO PHARMACEUTICALS CO., LTD.

ONO PHARMACEUTICALS CO., LTD. based in Osaka, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2019-10-17 ✅ Patent 10,899,729 granted on 2021-01-26
US20190315705A1
Chemistry; metallurgy

Method for producing bicyclic compound

#2 | 2019-05-09 ✅ Patent 10,501,442 granted on 2019-12-10
US20190135785A1
Chemistry; metallurgy

Quinoline derivative

#3 | 2015-04-23 ✅ Patent 9,388,157 granted on 2016-07-12
US20150112079A1
Chemistry; metallurgy

Bicyclic compound and use thereof for medical purposes

#4 | 2015-03-12 ✅ Patent 9,403,867 granted on 2016-08-02
US20150072934A1
Chemistry; metallurgy

Methods of producing anamorelin hydrochloride having controlled chloride content

#5 | 2014-07-03
US20140187630A1
Chemistry; metallurgy

NOVEL COMPOUND AND MEDICAL USE THEREOF

#6 | 2013-09-19 ✅ Patent 8,703,816 granted on 2014-04-22
US20130245074A1
Human necessities

Compound and medical use thereof

#7 | 2012-05-17 ✅ Patent 8,614,340 granted on 2013-12-24
US20120122964A1
Human necessities

Bicyclic compound and use thereof for medical purposes

#8 | 2010-06-24 ✅ Patent 8,115,014 granted on 2012-02-14
US20100160647A1
Chemistry; metallurgy

Ethynylindole compounds

#9 | 2010-03-11 ✅ Patent 7,968,572 granted on 2011-06-28
US20100063104A1
Human necessities

Nitrogen-containing heterocyclic compound and pharmaceutical application thereof

#10 | 2007-10-30 ✅ Patent 7,288,558 granted on 2007-10-30
US10467359
-

Pharmaceutical composition for treatment for urinary diseases comprising LPA receptor regulator

#11 | 2007-10-23 ✅ Patent 7,285,552 granted on 2007-10-23
US10472626
-

Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient

#12 | 2007-09-25 ✅ Patent 7,273,725 granted on 2007-09-25
US10493393
-

Human and mammalian stem cell-derived neuron survival factors

#13 | 2007-08-28 ✅ Patent 7,262,317 granted on 2007-08-28
US10333354
-

Freeze-dried preparation of n[o-(p-pivaloyloxybenzenasulfonylamino) benzoyl] glycine monosodium salt tetrahydrate and process for producing same

#14 | 2006-10-12 ✅ Patent 7,498,323 granted on 2009-03-03
US20060229301A1
Chemistry; metallurgy

Spiro-piperidine compounds and medicinal use thereof

#15 | 2006-08-31 ✅ Patent 7,291,644 granted on 2007-11-06
US20060194864A1
Chemistry; metallurgy

Indole derivatives

#16 | 2006-07-06 ✅ Patent 8,765,783 granted on 2014-07-01
US20060148844A1
Chemistry; metallurgy

Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation

#17 | 2006-06-22 ✅ Patent 7,300,917 granted on 2007-11-27
US20060135577A1
Chemistry; metallurgy

Remedy for chronic disease

#18 | 2006-02-09 ✅ Patent 7,629,369 granted on 2009-12-08
US20060030713A1
Chemistry; metallurgy

N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation

AssigneeID:

39628 ⎘